@article{9c90302cc59c4429a62d4f3604807f46,
title = "Pathways for CaMKII activation in disease",
keywords = "Calmodulin-dependent protein kinase II, Heart failure, Oxidation",
author = "Anderson, {Mark E.}",
note = "Funding Information: This work was supported by National Institutes of Health Grants R01HL70250 , R01HL079031 , and R01HL096652 and by Grant 08CVD01 from the Foundation Leducq , as part of the “Alliance for CaMKII Signaling in Heart.” Dr. Anderson is a named inventor on issued patents claiming to treat arrhythmias and heart failure by CaMKII inhibition and is a co-founder of Allosteros Therapeutics. ",
year = "2011",
month = sep,
doi = "10.1016/j.hrthm.2011.04.027",
language = "English (US)",
volume = "8",
pages = "1501--1503",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "9",
}